UNSPSC 85613102: Revision of infusion device in pancreas, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in pancreas, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0FWG33Z

UNSPSC 85613102 Revision of infusion device in pancreas, percutaneous approach is a Commodity code that shows little relevant recent activity aligned with its nominal clinical scope. The six recent state and local opportunities tagged to this code instead reflect healthcare services procurement across occupational health surveillance, independent medical evaluations for pension disability determinations, pharmacy benefit management, surgical care networks, temporary health professional staffing, and emergency medical services for detained youth — none of which involve the implantation, revision, or management of pancreatic infusion devices. The mismatch suggests this code is either rarely used by state and local buyers or has been applied inconsistently to healthcare service categories that fall outside its intended device-procurement scope.

The issuing bodies in the recent sample span county health systems, county pension boards, state transportation departments, county probation departments, and county commissioners' offices across Arizona, California, Florida, Texas, and Washington. Absent any recent solicitations for actual pancreatic medical devices or device-revision procedures, no representative opportunities aligned to the code's stated commodity can be named, and no geographic concentration in device procurement can be characterized. State and local buyers pursuing pancreatic infusion devices or revisions should verify their internal code assignments with procurement offices before pursuing opportunities tagged to this UNSPSC number.